30 June 2021PatentsAlex Baldwin

USPTO reveals post-Arthrex review process

As a result of the recent Supreme Court decision in US v Arthrex, the US Patent and Trademark Office (USPTO) issued new interim procedures on Tuesday, June 29, that give the office’s director the authority to rehear final Patent Trial and Appeal Board (PTAB) rulings.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

The PTAB’s post-Arthrex future

23 July 2021 Despite the latest challenge to its legitimacy, the US Patent Trial and Appeal Board has survived—and survive it must, say David McCombs, Joe Matal, and Eugene Goryunov of Haynes and Boone.

Patents

Apple and Intel weigh in on SCOTUS Arthrex review

4 December 2020 Apple and Intel, along with tech and IP groups, are urging the US Supreme Court to retain an administrative process for challenging patents.

Patents

USPTO urges Fed Circuit to wait for SCOTUS on Arthrex

13 August 2020 The USPTO wants a federal appeals court to hold off on a dispute over PTAB fees until the US Supreme Court has resolved Arthrex.